食品安全质量检测学报
食品安全質量檢測學報
식품안전질량검측학보
Journal of Food Safety & Quality
2015年
9期
3734-3740
,共7页
宋愿智%陈芳%牟霄%朱小红%廖德宏%王敏%孙文基%刘建书%甘志杰%许雪峰%张庆兰
宋願智%陳芳%牟霄%硃小紅%廖德宏%王敏%孫文基%劉建書%甘誌傑%許雪峰%張慶蘭
송원지%진방%모소%주소홍%료덕굉%왕민%손문기%류건서%감지걸%허설봉%장경란
汉莲牌红灵丹胶囊%配方论证%标志性成分%动物和人体试食试验
漢蓮牌紅靈丹膠囊%配方論證%標誌性成分%動物和人體試食試驗
한련패홍령단효낭%배방론증%표지성성분%동물화인체시식시험
Hanlian Monascus Ganoderma Salvia capsule%formula demonstration%symbolic ingredients%animal and human feeding test
目的对汉莲牌红曲灵芝丹参胶囊配方进行论证并对其标志性成分和功能学进行研究。方法依据中医理论和现代健康理念，对其配方进行论证，按照国家标准要求和相关规定，对其标志性成分进行鉴定，同时通过动物和人体试食试验来评价其功效。结果本品组分经典、科学合理，有效成分清楚、含量较高，每100 g中含洛伐他丁550 mg和丹参酮ⅡA 306 mg；动物和人体试食试验证明，各项指标均高于实验对照组，且差异显著(P<0.01或P<0.05)，具有较为显著的辅助降血脂功能。结论本品在预防和早期干预血脂异常及相关疾病方面具有显著的优势和较为广阔的市场前景。
目的對漢蓮牌紅麯靈芝丹參膠囊配方進行論證併對其標誌性成分和功能學進行研究。方法依據中醫理論和現代健康理唸，對其配方進行論證，按照國傢標準要求和相關規定，對其標誌性成分進行鑒定，同時通過動物和人體試食試驗來評價其功效。結果本品組分經典、科學閤理，有效成分清楚、含量較高，每100 g中含洛伐他丁550 mg和丹參酮ⅡA 306 mg；動物和人體試食試驗證明，各項指標均高于實驗對照組，且差異顯著(P<0.01或P<0.05)，具有較為顯著的輔助降血脂功能。結論本品在預防和早期榦預血脂異常及相關疾病方麵具有顯著的優勢和較為廣闊的市場前景。
목적대한련패홍곡령지단삼효낭배방진행론증병대기표지성성분화공능학진행연구。방법의거중의이론화현대건강이념，대기배방진행론증，안조국가표준요구화상관규정，대기표지성성분진행감정，동시통과동물화인체시식시험래평개기공효。결과본품조분경전、과학합리，유효성분청초、함량교고，매100 g중함락벌타정550 mg화단삼동ⅡA 306 mg；동물화인체시식시험증명，각항지표균고우실험대조조，차차이현저(P<0.01혹P<0.05)，구유교위현저적보조강혈지공능。결론본품재예방화조기간예혈지이상급상관질병방면구유현저적우세화교위엄활적시장전경。
ABSTRACT:Objective To demonstrate the formula of Hanlian brand Monascus Ganoderma Salvia capsule and to study its marker components and efficacy. Methods On the basis of traditional Chinese medicine theory and modern health concept, its formulation was demonstrated; according to the national standard requirements and relevant provisions, its marker components were identified;at the same time, its efficacy was evaluated through the animal and human trial tests. Results The components of this product was classic, scientific and reasonable, of which the effective constituents were clear and had a high content;it contained 550 mg lovastatin and 306 mg tanshinoneⅡA every 100 g. Through animal and human trial tests, it showed that the indexes of experimental group were higher than the control group respectively, and the difference was significant (P<0.01 or P<0.05), which showed that this capsule had a significant function to help reducing the blood lipid. Conclusion This capsule had a prominent advantage and relatively vast market prospect to prevent hyperlipidemia.
